Literature DB >> 29335100

Risk factors for and management of pupillary intraocular lens capture after intraocular lens transscleral fixation.

Se Rang Choi1, Ji Hoon Jeon1, Joon Won Kang1, Jang Won Heo2.   

Abstract

PURPOSE: To analyze risk factors and management of pupillary intraocular lens (IOL) capture after IOL transscleral fixation.
SETTING: Department of Ophthalmology, Seoul National University Hospital, Seoul, South Korea.
DESIGN: Retrospective case series.
METHODS: A chart review was performed of patients who had transscleral fixation of IOLs between January 1, 2012, and December 31, 2013. Eyes were divided into 2 groups depending on whether the IOL was pupillary captured. Perioperative corrected distance visual acuity (CDVA), intraocular pressure (IOP), spherical equivalent (SE) with refraction, axial length (AL), and total follow-up time were compared between the 2 groups. Ultrasound biomicroscopy images were used to analyze iris morphology and IOL position.
RESULTS: The chart review identified 138 patients, 112 patients of whom were included in this analysis. The preoperative and final mean CDVA, IOP, SE, AL, and most iris morphologic parameters were not significantly different between the 2 groups. In the pupillary capture IOL group, the mean age of patients with was younger, the anterior chamber depth (ACD) was narrower, and the rate of reverse pupillary block was higher (P = .003, P = .03, and P = .016, respectively). Intraocular lens decentration in the captured group was significantly larger (P = .002). Multiple logistic regression analysis showed that ACD, reverse pupillary block, and main decentration were associated with pupillary capture of the IOL.
CONCLUSIONS: Pupillary capture of an IOL occurred more in eyes with reverse pupillary block and poor IOL positioning. Accordingly, laser iridotomy must be considered for treatment.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Year:  2017        PMID: 29335100     DOI: 10.1016/j.jcrs.2017.08.021

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Clinical Outcomes and Lens Constant Optimization of the Zeiss CT Lucia 602 Lens Using a Modified Yamane Technique.

Authors:  Edward L Randerson; Joseph D Bogaard; Lisa R Koenig; Eileen S Hwang; Clinton C Warren; Steven B Koenig
Journal:  Clin Ophthalmol       Date:  2020-11-17

2.  Clinical observation of a novel technique: transscleral suture fixation of a foldable 3-looped haptics one-piece posterior chamber intraocular lens implantation through scleral pockets with intact conjunctiva.

Authors:  Shuang Ni; Wei Wang; Xiang Chen; Xingdi Wu; Suhong He; Yajuan Ma; Wen Xu
Journal:  BMC Ophthalmol       Date:  2019-05-09       Impact factor: 2.209

3.  Sutureless Intrascleral Posterior Chamber Intraocular Lens Fixation: Analysis of Clinical Outcomes and Postoperative Complications.

Authors:  Jiannan Liu; Wenxue Fan; Xinyu Lu; Shaomin Peng
Journal:  J Ophthalmol       Date:  2021-01-16       Impact factor: 1.909

4.  Outcomes of Transscleral Two-Point Fixation Versus Closed Continuous-Loop Four-Point Fixation of Intraocular Lens in Subluxated Lens Secondary to Marfan Syndrome.

Authors:  Xiang Gao; Wenting Zhu; Jingyi Tian; Xiaolei Sun; Ziyi Ni; Gongqiang Yuan; Jingjing Zhang
Journal:  Ophthalmol Ther       Date:  2022-05-20

5.  One-Year Outcomes of Modified Technique for Scleral Fixation of a Three-Piece Intraocular Lens Without Conjunctival Opening.

Authors:  Hongfei Ye; Shiguang Zhang; Wei Mi; Ping Fei; Peiquan Zhao
Journal:  Front Med (Lausanne)       Date:  2022-06-02

6.  Double-Needle Yamane Repositioning of a Previous Yamane Fixation.

Authors:  Sangeethabalasri Pugazhendhi; Balamurali Ambati; Allan A Hunter
Journal:  Case Rep Ophthalmol       Date:  2019-12-17

7.  Rectangular loop suture to correct iris capture of the posterior chamber intraocular lens.

Authors:  Ke Lin; Zhixiang Hu; Zhong Lin; Tianyu Chen; Yongping Tang; Ronghan Wu
Journal:  BMC Ophthalmol       Date:  2020-09-25       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.